Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Oragenics, Inc.

AMEX: OGENHealthcare / Biotechnology / USA
1.00-0.07-6.54%Vol 2 115 7881Y Perf -71.71%
Dec 10th, 2018 14:02
BID0.99 ASK1.00
Open1.04 Previous Close1.07
Pre-Market1.03 After-Trading1.06
 -0.04 -3.74%  -0.01 -0.93%
Target Price
5.00 
Analyst Rating
— 0.00
Potencial %
405.05 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
100/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
100/100/100 
Growth Ranking
★★★+     55.46
Insiders Shares Cnt. % 3/6/12M
100/100/100 
Income Ranking
 —    -
Market Cap (mil)29 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
16.23 
Earnings Date
13th Nov 2018

Today's Price Range

0.931.07

 

52wk Range

0.384.20

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
1.90%
3 Months
160.98%
6 Months
-30.97%
1 Year
-71.71%
3 Years
-91.37%
5 Years
-96.70%

Quotes

Name / TickerPriceChg.Chg.%
OGEN1.00-0.0700-6.54
AAPL169.270.78000.46
GOOG1 040.083.50000.34
MSFT106.451.63001.56
XOM75.97-1.6700-2.15
WFC48.77-1.4900-2.96
JNJ144.55-0.8800-0.61
FB141.093.67002.67
GE6.94-0.0700-1.00
JPM101.29-2.0000-1.94
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
8.90
Current Ratio
9.90
Long Term Debt to Total Capital
0.83
Total Debt to Equity
0.03
Interest Coverage
-154.60
Leverage Ratio 11.40
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-
EBITDA Margin
-
Pre-tax Profit Margin
-
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
5.55
PS Ratios
-97.70
Price to Cash Flow
-
Price to Free Cash Flow
-5.30
Cash Flow Per Share
-1.07
Price to Tangible Book
5.55
Book Value per Share
0.24
Enterprise Value (in ths.)
32 927
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-122.92
ROE last 12 Months
-289.39
Return on Assets (5Y Avg)
-91.56
ROA last 12 Months
-97.06
Return on Capital (5Y Avg)
-184.78
ROC last 12 Months
-275.68
Return on invested Capital Q
-169.55
Return on invested Capital Y
-418.39
Assets Turnover
0.00
Receivables Turnover
0.00
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
0
Revenue per Share
0.00
Revenue Growth 3 Years
-32.94
Revenue Growth 5 Years
-22.90
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.22-0.35-59.09
Q02 2018-0.41-0.387.32
Q02 2017--0.20-
Q01 2017--0.40-
Q03 2016-0.04-0.040.00
Q02 2016--0.05-
Q01 2016--0.05-
Q04 2015--0.06-
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.1726.09Positive
12/2018 FY-0.8212.77Positive
3/2019 QR-0.250.00-
12/2019 FY-0.6116.44Positive
Next Report Date-
Estimated EPS Next Report-0.22
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume2 115 788
Shares Outstanding (in ths.)29 430
Trades Count2 615
Dollar Volume2 036 657
Avg. Volume2 617 490
Avg. Weekly Volume5 845 906
Avg. Monthly Volume3 739 902
Avg. Quarterly Volume8 525 090

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

24%76%

Bearish Bullish

52%48%

Bearish Bullish

62%38%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
1 (100.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Rating--Strong Buy
1.00

There are no comments yet.

News